MXPA06014821A - Arial de subunidades del virus del sindrome reproductivo y respiratorio porcino. - Google Patents

Arial de subunidades del virus del sindrome reproductivo y respiratorio porcino.

Info

Publication number
MXPA06014821A
MXPA06014821A MXPA06014821A MXPA06014821A MXPA06014821A MX PA06014821 A MXPA06014821 A MX PA06014821A MX PA06014821 A MXPA06014821 A MX PA06014821A MX PA06014821 A MXPA06014821 A MX PA06014821A MX PA06014821 A MXPA06014821 A MX PA06014821A
Authority
MX
Mexico
Prior art keywords
prrsv
dna
group
contiguous nucleotides
orf1
Prior art date
Application number
MXPA06014821A
Other languages
English (en)
Spanish (es)
Inventor
Eric M Vaughn
Richard Stammer
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of MXPA06014821A publication Critical patent/MXPA06014821A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA06014821A 2004-06-17 2005-06-17 Arial de subunidades del virus del sindrome reproductivo y respiratorio porcino. MXPA06014821A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58135004P 2004-06-17 2004-06-17
US11/154,617 US7722878B2 (en) 2004-06-17 2005-06-16 PRRSV subunit vaccines
PCT/US2005/021973 WO2006002193A2 (en) 2004-06-17 2005-06-17 Prrsv subunit vaccines

Publications (1)

Publication Number Publication Date
MXPA06014821A true MXPA06014821A (es) 2007-03-26

Family

ID=35431312

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06014821A MXPA06014821A (es) 2004-06-17 2005-06-17 Arial de subunidades del virus del sindrome reproductivo y respiratorio porcino.

Country Status (14)

Country Link
US (1) US7722878B2 (https=)
EP (1) EP1755664B1 (https=)
JP (1) JP2008503221A (https=)
KR (1) KR20070028431A (https=)
AR (1) AR049825A1 (https=)
AU (1) AU2005258092A1 (https=)
BR (1) BRPI0510930A (https=)
CA (1) CA2570778A1 (https=)
DK (1) DK1755664T3 (https=)
ES (1) ES2546933T3 (https=)
MX (1) MXPA06014821A (https=)
RU (1) RU2007101531A (https=)
TW (1) TW200603825A (https=)
WO (1) WO2006002193A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
MXPA01010681A (es) 1999-04-22 2003-08-20 Us Agriculture Vacuna de sindrome respiratorio y reproductiva porcina a base de ja-142 aislado.
RU2007101725A (ru) 2004-06-18 2008-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) Идентификация инфицированных вирусом и вакцинированных вирусом организмов
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
CA2894069C (en) 2005-06-24 2019-02-26 Regents Of The University Of Minnesota Prrs viruses, infectious clones, mutants thereof, and methods of use
US8436337B2 (en) * 2009-05-12 2013-05-07 The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity Amorphous multi-component metallic thin films for electronic devices
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
ES2550258T3 (es) 2011-02-17 2015-11-05 Boehringer Ingelheim Vetmedica Gmbh Nueva cepa del PRRSV europea
WO2012129176A1 (en) * 2011-03-18 2012-09-27 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon
KR20140033096A (ko) 2011-05-07 2014-03-17 래보래토리오 아비-멕스, 에스.에이. 데 씨.브이. 바이러스성 벡터를 이용한 prrs에 대한 재조합 백신
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9099230B2 (en) 2012-11-12 2015-08-04 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State Univesity Amorphous metal thin-film non-linear resistor
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EA039060B1 (ru) 2013-12-20 2021-11-29 Бёрингер Ингельхайм Ветмедика Гмбх Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773908B1 (en) * 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof

Also Published As

Publication number Publication date
TW200603825A (en) 2006-02-01
DK1755664T3 (en) 2015-08-24
KR20070028431A (ko) 2007-03-12
AU2005258092A1 (en) 2006-01-05
WO2006002193A2 (en) 2006-01-05
ES2546933T3 (es) 2015-09-30
US20080038293A1 (en) 2008-02-14
EP1755664B1 (en) 2015-06-10
RU2007101531A (ru) 2008-07-27
EP1755664A2 (en) 2007-02-28
CA2570778A1 (en) 2006-01-05
US7722878B2 (en) 2010-05-25
JP2008503221A (ja) 2008-02-07
WO2006002193A3 (en) 2006-03-02
AR049825A1 (es) 2006-09-06
BRPI0510930A (pt) 2007-11-20

Similar Documents

Publication Publication Date Title
MXPA06014821A (es) Arial de subunidades del virus del sindrome reproductivo y respiratorio porcino.
Wang et al. A natural recombinant PRRSV between HP‐PRRSV JXA 1‐like and NADC 30‐like strains
AU2021201224B2 (en) PRRS virus variant, European PRRS virus cDNA clone, and uses thereof
Kwang et al. Antibody and cellular immune responses of swine following immunisation with plasmid DNA encoding the PRRS virus ORF’s 4, 5, 6 and 7
US20220031831A1 (en) Immunogenic compositions for african swine fever virus
JP5890469B2 (ja) 高病原性ブタ繁殖・呼吸障害症候群（ｈｐｐｒｒｓ）のワクチン
CN109803678B (zh) 抗猪细小病毒的疫苗
EP1838343A2 (en) Improved prrs vaccines
US9315781B2 (en) Infectious CDNA clone of european PRRS virus and uses thereof
Mardani et al. Infectious bronchitis viruses with a novel genomic organization
CN119698293A (zh) 重组猪冠状病毒
Zulperi et al. Sequence and phylogenetic analysis of S1, S2, M, and N genes of infectious bronchitis virus isolates from Malaysia
Hedges et al. Genetic variation in open reading frame 2 of field isolates and laboratory strains of equine arteritis virus
RU2687150C2 (ru) Не встречающийся в природе вирус репродуктивно-респираторного синдрома свиней (bppcc) и способы применения
EP1200132B2 (en) Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
KR20200037570A (ko) 돼지 생식기 호흡기 증후군 바이러스의 키메릭 변이주
CN111996202B (zh) 一种重组o型口蹄疫病毒vp1基因的塞内卡重组病毒、重组疫苗株及其制备方法和应用
Cai et al. Construction and characterization of a recombinant canine adenovirus expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus
US20250121047A1 (en) Chimeric virus expressing porcine productive and respiratory syndrome virus-derived peptide and vaccine composition comprising same
Ignjatovic et al. Infectious Bronchitis Viruses with a Novel
AU2003209766B2 (en) Nucleic acid sequence comprising the RNA packaging signal of a group 1 coronavirus and the applications thereof
Indik et al. Differentiation of porcine reproductive and respiratory syndrome virus European vaccine strains from Czech field isolates by restriction fragment length polymorphism analysis of ORF5 gene
WO2025012350A1 (en) Vectors expressing attenuated rna virus of the family arteriviridae and uses thereof
CHOULJENKO et al. Elucidation of the Genomic Nucleotide Sequence of Bovine Coronavirus and Analysis of Cryptic Leader
STORZ et al. Elucidation of the Genomic Nucleotide Sequence of Bovine Coronavirus and Analysis of Cryptic Leader

Legal Events

Date Code Title Description
FA Abandonment or withdrawal